Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danilo Hamilko de Barros"'
Autor:
Ericles Andrei Bellei, André Vicente Esteves de Carvalho, Beatriz Magalhães Eng, Carla Tozato, Danilo Hamilko de Barros, Erika Yumi Tamashiro, Gleison Vieira Duarte, Rafael Toledo Rodrigues de Fátima, Renata Ferreira Magalhães, Roberto Souto da Silva, Wagner Guimarães Galvão Cesar, Felipe Garutti Thies
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2797-2815 (2023)
Abstract Introduction Hidradenitis suppurativa (HS) is a chronic skin condition causing considerable distress. It impacts mobility, social interaction, and quality of life. In Brazil, there is a notable gap in epidemiological data and patient experie
Externí odkaz:
https://doaj.org/article/eaca60803eb0481faa43cd82aaed7a03
Autor:
Eloisa Doubrawa, Renê Augusto de Mattos Ricca, Tiago Osternack Malucelli, Vanessa Irusta Dal Pizzol, Danilo Hamilko de Barros, Eduardo Santos Paiva
Publikováno v:
Revista Brasileira de Reumatologia, Vol 52, Iss 4, Pp 653-655 (2012)
Os agentes anti-TNF-α emergiram como potente tratamento para os pacientes com artrite reumatoide que não respondem às drogas modificadoras de doença convencionais. Por induzir à imunossupressão, essas drogas têm como principal complicação o
Externí odkaz:
https://doaj.org/article/c71359abe7d44fcbb7a5776205b7444b
Autor:
Tiago Osternack Malucelli, Renê Augusto de Mattos Ricca, Danilo Hamilko de Barros, Eloisa Doubrawa, Vanessa Irusta Dal Pizzol, Eduardo dos Santos Paiva
Publikováno v:
Revista Brasileira de Reumatologia. 52:653-655
Anti-TNF-α agents have emerged as a potent treatment for patients with rheumatoid arthritis unresponsive to conventional disease-modifying antirheumatic drugs. Increased susceptibility to infections induced by these drugs is the main complication of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::336d5b394092d8c5a1a95c0b07f0f3d0
https://doi.org/10.1590/s0482-50042012000400015
https://doi.org/10.1590/s0482-50042012000400015
Autor:
Eloisa, Doubrawa, Renê Augusto de Mattos, Ricca, Tiago Osternack, Malucelli, Vanessa Irusta Dal, Pizzol, Danilo Hamilko de, Barros, Eduardo Santos, Paiva
Publikováno v:
Revista brasileira de reumatologia. 52(4)
Anti-TNF-α agents have emerged as a potent treatment for patients with rheumatoid arthritis unresponsive to conventional disease-modifying antirheumatic drugs. Increased susceptibility to infections induced by these drugs is the main complication of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2a476d572d021258c92c298e8cabe1e
https://pubmed.ncbi.nlm.nih.gov/22885430
https://pubmed.ncbi.nlm.nih.gov/22885430